Hiroyuki Kanoh

Effects of Sustained‐Release Beraprost in Patients With Primary Glomerular Disease or Nephrosclerosis: CASSIOPEIR Study Results

Jianghua Chen, H. Chen, T. Fujita, 2020, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

Orally active prostacyclin analogue beraprost sodium in patients with chronic kidney disease: a randomized, double-blind, placebo-controlled, phase II dose finding trial

T. Fujita, F. Gejyo, H. Origasa, 2015, BMC Nephrology.

A multinational phase IIb/III trial of beraprost sodium, an orally active prostacyclin analogue, in patients with primary glomerular disease or nephrosclerosis (CASSIOPEIR trial), rationale and study design

T. Fujita, H. Origasa, T. Kiriyama, 2014, BMC Nephrology.

Numerical Foundation of Hot-Electron Diffraction Experiment Based on Ballistic Electron Emission Microscope

K. Furuya, N. Machida, Hiroyuki Kanoh, 2004 .